Back to Search

Phase II Trial With Safety Lead in of Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas


  • Protocol Number: 202005165
  • Principal Investigator: Cashen, Amanda
  • Cancer Types: Leukemia, Myeloma, and Hematologic, Lymphoma

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions